SCHEMBL4640832

SCHEMBL4640832

CCc1ccc(C(=O)OC(CC)C(C)(C)C)c(C(=O)O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 5/20 0.38
USP2 O75604 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CFD P00746 1/20 0.35
MAPT P10636 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
PPARA Q07869 2/20 0.35
PPARG P37231 1/20 0.35
KLKB1 P03952 1/20 0.34
CTSB P07858 1/20 0.34
MMP9 P14780 1/20 0.34
DNMT1 P26358 1/20 0.34
DNMT3B Q9UBC3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640829 0.93 MEN1 (0.37) METAP2MEN1KMT2AALDH1A1USP2
SCHEMBL4640014 0.87 ALDH1A1 (0.44) METAP2MEN1KMT2AALDH1A1USP2
SCHEMBL4641293 0.86 CSNK2A1 (0.41) MEN1KMT2AALDH1A1MAPT
SCHEMBL4640103 0.86 METAP2 (0.40) METAP2MEN1KMT2AALDH1A1USP2
SCHEMBL4639939 0.85 KDM4E (0.40) ALDH1A1HPGDSMN1; SMN2AKR1C2
SCHEMBL4639930 0.85 ALDH1A1 (0.36) MEN1KMT2AALDH1A1RAB9A
SCHEMBL4642995 0.84 MEN1 (0.35) MEN1KMT2AALDH1A1TSHR
SCHEMBL4640001 0.82 SMN1; SMN2 (0.36) MEN1KMT2AALDH1A1HPGDTSHR
SCHEMBL15675541 0.82 ALDH1A1 (0.52) MEN1KMT2AALDH1A1HPGDTSHR
SCHEMBL4640470 0.82 AKR1C3 (0.41) METAP2MEN1KMT2AALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX METAP2 4546/4885MEN1 3562/4885KMT2A 3313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.